cgp 35348 has been researched along with (endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartolini, A; Casamenti, F; Galeotti, N; Ghelardini, C; Gualtieri, F; Malmberg-Aiello, P; Pepeu, G | 1 |
1 other study(ies) available for cgp 35348 and (endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide
| Article | Year |
|---|---|
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8.
Topics: 4-Aminobenzoic Acid; Analgesics; Animals; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Indoles; Male; Mice; Organophosphorus Compounds; Pain Threshold; para-Aminobenzoates; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides | 1996 |